References
- Bedford L , LoweJ, DickLR, MayerRJ, BrownellJE. Ubiquitin-like protein conjugation and the ubiquitin-proteasome system as drug targets. Nat. Rev. Drug Discov.10 (1), 29–46 (2011).
- Landré V , RotblatB, MelinoS, BernassolaF, MelinoG. Screening for E3-ubiquitin ligase inhibitors: challenges and opportunities. Oncotarget5 (18), 7988–8013 (2014).
- Goldenberg SJ , MarblestoneJG, MatternMR, NicholsonB. Strategies for the identification of ubiquitin ligase inhibitors. Biochem. Soc. Trans.38 (Pt 1), 132–136 (2010).
- Skaar JR , PaganJK, PaganoM. SCF ubiquitin ligase-targeted therapies. Nat. Rev. Drug Discov.13 (12), 889–903 (2014).
- Berndsen CE , WolbergerC. New insights into ubiquitin E3 ligase mechanism. Nat. Struct. Mol. Biol.21 (4), 301–307 (2014).
- Bernassola F , KarinM, CiechanoverA, MelinoG. The HECT family of E3 ubiquitin ligases: multiple players in cancer development. Cancer Cell14 (1), 10–21 (2008).
- Kamadurai HB , QiuY, DengAet al. Mechanism of ubiquitin ligation and lysine prioritization by a HECT E3. eLife2, e00828 (2013).
- Rossi M , RotblatB, AnsellKet al. High throughput screening for inhibitors of the HECT ubiquitin E3 ligase ITCH identifies antidepressant drugs as regulators of autophagy. Cell Death Dis.5, e1203 (2014).
- Peter S , BultinckJ, MyantKet al. Tumor cell-specific inhibition of MYC function using small molecule inhibitors of the HUWE1 ubiquitin ligase. EMBO Mol. Med.6 (12), 1525–1541 (2014).
- Sodir NM , EvanGI. Finding cancer's weakest link. Oncotarget2 (12), 1307–1313 (2011).
- Mund T , LewisMJ, MaslenS, PelhamHR. Peptide and small molecule inhibitors of HECT-type ubiquitin ligases. Proc. Natl Acad. Sci. USA111 (47), 16736–16741 (2014).
- Heinis C , RutherfordT, FreundS, WinterG. Phage-encoded combinatorial chemical libraries based on bicyclic peptides. Nat. Chem. Biol.5 (7), 502–507 (2009).
- Han Z , LuJ, LiuYet al. Small-molecule probes targeting the viral PPxY-Host Nedd4 interface block egress of a broad range of RNA viruses. J. Virol.88 (13), 7294–7306 (2014).
- Dompe N , RiversCS, LiLet al. A whole-genome RNAi screen identifies an 8q22 gene cluster that inhibits death receptor-mediated apoptosis. Proc. Natl Acad. Sci. USA108 (43), E943–E951 (2011).
- Bradley A , ZhengH, ZiebarthAet al. EDD enhances cell survival and cisplatin resistance and is a therapeutic target for epithelial ovarian cancer. Carcinogenesis35 (5), 1100–1109 (2014).
- Chen D , YoonJB, GuW. Reactivating the ARF-p53 axis in AML cells by targeting ULF. Cell Cycle9 (15), 2946–2951 (2010).
- Chio IIC , SasakiM, GhazarianDet al. TRADD contributes to tumour suppression by regulating ULF-dependent p19Arf ubiquitylation. Nat. Cell Biol.14 (6), 625–633 (2012).
- Kathman SG , SpanI, SmithATet al. A small molecule that switches a ubiquitin ligase from a processive to a distributive enzymatic mechanism. J. Am. Chem. Soc. doi:10.1021/jacs.5b06839 (2015) ( Epub ahead of print).
- Opitz R , MullerM, ReuterCet al. A modular toolkit to inhibit proline-rich motif-mediated protein-protein interactions. Proc. Natl Acad. Sci. USA112 (16), 5011–5016 (2015).
- Rotin D , KumarS. Physiological functions of the HECT family of ubiquitin ligases. Nat. Rev. Mol. Cell Biol.10 (6), 398–409 (2009).